Video
Microbiomepost conducted an exclusive interview with Jiri Snaidr, Founder and CEO at Vermicon AG, about the possibility to combine Fluorescence In Situ Hybridization (FISH) and Digital PCR (dPCR) for advanced…
Microbiomepost conducted an exclusive interview with Eric Daliri, from Vilnius University, about the possibility of prevent diabetes modulating gut microbiome.
Microbiomepost conducted an exclusive interview with Nina Vinot, Bioprox Healthcare, about the new frontiers of the microbiome revolution: the role of soil microbiome in the agriculture space.
Alessio Fasano, Chair of the Congress, shares an overview of the event and the future challenges.
During IPC 2024, George Paraskevakos shared recent updates on market developments and an overview of the Biotic-related survey.
AB-Biotics recently appointed to the IPA board of directors. What opportunities and future developments? We discussed this with Miquel Bonachera.
Satish Chandran, President and Chief Executive Officer at Prodigy Biotech, Inc., details the company's program aimed at treating alcoholic liver disease, spotlighting Enterococcus faecalis as the primary antagonist.
Aran Singanayagam, research group leader at Imperial College London (UK), examined how disturbances in the airway microbiome are instrumental in the development of chronic lung diseases.
An exclusive interview with Daniel Brownell, Senior Director of Research & Development at AOBiome Therapeutics, whose core technology is ammonia oxidizing bacteria, formulated as a topical suspension of bacteria applied…
Antonio Gomes, Principal Scientist at Xbiome, talks about employing deep learning techniques to refine the prediction of natural product structures directly from gene sets.
